Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC5A1 | P13866 | 14/20 | 1.00 |
| ▸ | SLC5A2 | P31639 | 5/20 | 1.00 |
| ▸ | SLC28A3 | Q9HAS3 | 3/20 | 1.00 |
| ▸ | HPGD | P15428 | 2/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 1/20 | 1.00 |
| ▸ | MAPT | P10636 | 1/20 | 1.00 |
| ▸ | THRB | P10828 | 1/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 1/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 1/20 | 1.00 |
| ▸ | SLC28A2 | O43868 | 1/20 | 1.00 |
| ▸ | EPHX2 | P34913 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phlorizin SCHEMBL18058585 | 1.00 | SLC5A1 (1.00) | SLC5A1SLC5A2SLC28A3HPGDHSD17B10 | |
| Phlorizin SCHEMBL16421567 | 1.00 | SLC5A1 (1.00) | SLC5A1SLC5A2SLC28A3HPGDHSD17B10 | |
| Phlorizin SCHEMBL2826870 | 1.00 | SLC5A1 (1.00) | SLC5A1SLC5A2SLC28A3HPGDHSD17B10 | |
| Phlorizin SCHEMBL17290 | 1.00 | SLC5A1 (1.00) | SLC5A1SLC5A2SLC28A3HPGDHSD17B10 | |
| Phlorizin SCHEMBL22022720 | 1.00 | SLC5A1 (1.00) | SLC5A1SLC5A2SLC28A3HPGDHSD17B10 | |
| Phlorizin SCHEMBL23802544 | 1.00 | SLC5A1 (1.00) | SLC5A1SLC5A2SLC28A3HPGDHSD17B10 | |
| Phlorizin SCHEMBL7647026 | 0.99 | SLC5A1 (0.98) | SLC5A1SLC5A2SLC28A3HPGDHSD17B10 | |
| Phlorizin SCHEMBL28823647 | 0.99 | SLC5A1 (0.98) | SLC5A1SLC5A2SLC28A3HPGDHSD17B10 | |
| Phlorizin SCHEMBL18523288 | 0.99 | SLC5A1 (0.98) | SLC5A1SLC5A2SLC28A3HPGDHSD17B10 | |
| Phlorizin SCHEMBL8861774 | 0.99 | SLC5A1 (0.98) | SLC5A1SLC5A2SLC28A3HPGDHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 5199 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250386844-A1 | HEALTHY SWEETENERS COMPRISING ANTIOXIDANTS | Apple Sugar LLC (US) | 2025-12-25 | — | — | US | claimed |
| EP-4658090-A1 | SIAMENOSIDE I SWEETENED BEVERAGES WITH MOGROSIDE BLENDS | The Coca-Cola Company (US) | 2025-12-10 | — | — | EP | claimed |
| EP-4655410-A2 | O-METHYLATION OF PHENOLIC SUBSTANCES VIA FUNGAL O-METHYLTRANSFERASE | Symrise AG (DE) | 2025-12-03 | — | — | EP | claimed |
| US-20250351855-A1 | TASTE OF CONSUMABLES | THE PRODUCT MAKERS (AUSTRALIA) PTY LTD (AU) | 2025-11-20 | — | — | US | claimed |
| EP-3780974-B1 | GUAVA EXTRACT | PM INT AG (LU) | 2025-11-12 | — | — | EP | claimed |
| US-20250340675-A1 | NEW HYALURONIC ACID DERIVATIVES AS INNOVATIVE FILLERS | WiQo S.P.A. (IT) | 2025-11-06 | — | — | US | claimed |
| US-20250313807-A1 | SYSTEMS AND METHODS FOR CHARACTERIZATION OF POLYCYSTIC KIDNEY DISEASE | UNIVERSITY OF WASHINGTON (US) | 2025-10-09 | — | — | US | claimed |
| EP-4609911-A2 | COMPOUNDS EFFECTIVE IN TREATING HEPATOTOXICITY AND FATTY LIVER DISEASES AND USES THEREOF | Sinew Pharma Inc. (TW) | 2025-09-03 | — | — | EP | claimed |
| US-12402645-B2 | High-purity mogrosides and process for their purification | PURECIRCLE SDN. BHD. (MY) | 2025-09-02 | — | — | US | claimed |
| US-20250248432-A1 | MIXTURE COMPRISING D-ALLULOSE AND TASTE MODIFYING COMPOUNDS | SYMRISE AG (DE) | 2025-08-07 | — | — | US | claimed |
| WO-1996018382-A1 | USE OF FLAVONOIDS AS IMMUNOMODULATING OR IMMUNO-PROTECTIVE AGENTS IN COSMETIC AND DERMATOLOGICAL PREPARATIONS | BEIERSDORF AG (DE) | 1996-06-20 | — | — | WO | claimed |
| EP-0445255-B1 | TREATMENT OF CONDITIONS AND DISEASE | HYAL PHARMA CORP (CA) | 1995-12-06 | — | — | EP | claimed |
| EP-0666735-A1 | RETINOL CONTAINING COSMETIC COMPOSITION | UNILEVER PLC (GB) | 1995-08-16 | — | — | EP | claimed |
| WO-1994020627-A1 | MANNOSE OR XYLOSE BASED POSITIVE SELECTION | SANDOZ LTD. (CH) | 1994-09-15 | — | — | WO | claimed |
| WO-1994009756-A1 | RETINOL CONTAINING COSMETIC COMPOSITION | UNILEVER PLC (GB) | 1994-05-11 | — | — | WO | claimed |
| EP-0445255-A1 | TREATMENT OF CONDITIONS AND DISEASE. | NORPHARMCO INC (CA) | 1991-09-11 | — | — | EP | claimed |
| WO-1991004058-A2 | TREATMENT OF CONDITIONS AND DISEASE | NORPHARMCO INC. (CA) | 1991-04-04 | — | — | WO | claimed |
| US-4959355-A | GLUCOSE TRANSPORT BLOCKER | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 1990-09-25 | — | — | US | claimed |
| US-4565806-A | Composition and method for rational treatment of cancer | SETAELAE KAI M E | 1986-01-21 | — | — | US | claimed |
| US-4152869-A | Propagating woody plant material | NATIONAL SEED DEVELOPMENT ORGANISATION LIMITED (GB) | 1979-05-08 | — | — | US | claimed |